• Sorry! To unlock all site features, we'll need to collect some information from you.

  • Unit 8.6: The Zotarolimus Program for Drug-Eluting Stents

    William A. Gray, MD — Columbia University Medical Center, Cardiovascular Research Foundation

    Duration:1 hour

    Faculty Disclosure

    Disclosures not available

    Learning Objectives

    • Understand the pharmacologic basis of the use of zotarolimus
    • Compare the Endeavor and TriMaxx stent platforms
    • Review zotarolimus clinical programs and trial results to date